Click for best price
Regenerative Drugs Market Size, Share 2022
Regenerative drugs are used to repair, replace, and regenerate tissues and organs affected by injury, disease, or natural aging process.
This report contains market size and forecasts of Regenerative Drugs in Global, including the following market information:
Global Regenerative Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Regenerative Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Synthetic Material Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Regenerative Drugs include Stryker, Zimmer Biomet Holdings, Medtronic, Athersys, STEMCELL Technologies, Organogenesis, Integra Lifesciences, Acelity and Isto Biologics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Regenerative Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Regenerative Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Regenerative Drugs Market Segment Percentages, by Type, 2021 (%)
Synthetic Material
Biologically Derived Material
Genetically Engineered Material
Others
Global Regenerative Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Regenerative Drugs Market Segment Percentages, by Application, 2021 (%)
Cardiovascular
Dermatology
Musculoskeletal
Neurology
Others
Global Regenerative Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Regenerative Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Regenerative Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Regenerative Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Stryker
Zimmer Biomet Holdings
Medtronic
Athersys
STEMCELL Technologies
Organogenesis
Integra Lifesciences
Acelity
Isto Biologics
CryoLife
| Report Attributes |
Report Details |
| Report Title |
Regenerative Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Regenerative Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Regenerative Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Regenerative Drugs Overall Market Size
2.1 Global Regenerative Drugs Market Size: 2021 VS 2028
2.2 Global Regenerative Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Regenerative Drugs Players in Global Market
3.2 Top Global Regenerative Drugs Companies Ranked by Revenue
3.3 Global Regenerative Drugs Revenue by Companies
3.4 Top 3 and Top 5 Regenerative Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Regenerative Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Regenerative Drugs Players in Global Market
3.6.1 List of Global Tier 1 Regenerative Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Regenerative Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Regenerative Drugs Market Size Markets, 2021 & 2028
4.1.2 Synthetic Material
4.1.3 Biologically Derived Material
4.1.4 Genetically Engineered Material
4.1.5 Others
4.2 By Type - Global Regenerative Drugs Revenue & Forecasts
4.2.1 By Type - Global Regenerative Drugs Revenue, 2017-2022
4.2.2 By Type - Global Regenerative Drugs Revenue, 2023-2028
4.2.3 By Type - Global Regenerative Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Regenerative Drugs Market Size, 2021 & 2028
5.1.2 Cardiovascular
5.1.3 Dermatology
5.1.4 Musculoskeletal
5.1.5 Neurology
5.1.6 Others
5.2 By Application - Global Regenerative Drugs Revenue & Forecasts
5.2.1 By Application - Global Regenerative Drugs Revenue, 2017-2022
5.2.2 By Application - Global Regenerative Drugs Revenue, 2023-2028
5.2.3 By Application - Global Regenerative Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Regenerative Drugs Market Size, 2021 & 2028
6.2 By Region - Global Regenerative Drugs Revenue & Forecasts
6.2.1 By Region - Global Regenerative Drugs Revenue, 2017-2022
6.2.2 By Region - Global Regenerative Drugs Revenue, 2023-2028
6.2.3 By Region - Global Regenerative Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Regenerative Drugs Revenue, 2017-2028
6.3.2 US Regenerative Drugs Market Size, 2017-2028
6.3.3 Canada Regenerative Drugs Market Size, 2017-2028
6.3.4 Mexico Regenerative Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Regenerative Drugs Revenue, 2017-2028
6.4.2 Germany Regenerative Drugs Market Size, 2017-2028
6.4.3 France Regenerative Drugs Market Size, 2017-2028
6.4.4 U.K. Regenerative Drugs Market Size, 2017-2028
6.4.5 Italy Regenerative Drugs Market Size, 2017-2028
6.4.6 Russia Regenerative Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Regenerative Drugs Market Size, 2017-2028
6.4.8 Benelux Regenerative Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Regenerative Drugs Revenue, 2017-2028
6.5.2 China Regenerative Drugs Market Size, 2017-2028
6.5.3 Japan Regenerative Drugs Market Size, 2017-2028
6.5.4 South Korea Regenerative Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Regenerative Drugs Market Size, 2017-2028
6.5.6 India Regenerative Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Regenerative Drugs Revenue, 2017-2028
6.6.2 Brazil Regenerative Drugs Market Size, 2017-2028
6.6.3 Argentina Regenerative Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Regenerative Drugs Revenue, 2017-2028
6.7.2 Turkey Regenerative Drugs Market Size, 2017-2028
6.7.3 Israel Regenerative Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Regenerative Drugs Market Size, 2017-2028
6.7.5 UAE Regenerative Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Stryker
7.1.1 Stryker Corporate Summary
7.1.2 Stryker Business Overview
7.1.3 Stryker Regenerative Drugs Major Product Offerings
7.1.4 Stryker Regenerative Drugs Revenue in Global Market (2017-2022)
7.1.5 Stryker Key News
7.2 Zimmer Biomet Holdings
7.2.1 Zimmer Biomet Holdings Corporate Summary
7.2.2 Zimmer Biomet Holdings Business Overview
7.2.3 Zimmer Biomet Holdings Regenerative Drugs Major Product Offerings
7.2.4 Zimmer Biomet Holdings Regenerative Drugs Revenue in Global Market (2017-2022)
7.2.5 Zimmer Biomet Holdings Key News
7.3 Medtronic
7.3.1 Medtronic Corporate Summary
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Regenerative Drugs Major Product Offerings
7.3.4 Medtronic Regenerative Drugs Revenue in Global Market (2017-2022)
7.3.5 Medtronic Key News
7.4 Athersys
7.4.1 Athersys Corporate Summary
7.4.2 Athersys Business Overview
7.4.3 Athersys Regenerative Drugs Major Product Offerings
7.4.4 Athersys Regenerative Drugs Revenue in Global Market (2017-2022)
7.4.5 Athersys Key News
7.5 STEMCELL Technologies
7.5.1 STEMCELL Technologies Corporate Summary
7.5.2 STEMCELL Technologies Business Overview
7.5.3 STEMCELL Technologies Regenerative Drugs Major Product Offerings
7.5.4 STEMCELL Technologies Regenerative Drugs Revenue in Global Market (2017-2022)
7.5.5 STEMCELL Technologies Key News
7.6 Organogenesis
7.6.1 Organogenesis Corporate Summary
7.6.2 Organogenesis Business Overview
7.6.3 Organogenesis Regenerative Drugs Major Product Offerings
7.6.4 Organogenesis Regenerative Drugs Revenue in Global Market (2017-2022)
7.6.5 Organogenesis Key News
7.7 Integra Lifesciences
7.7.1 Integra Lifesciences Corporate Summary
7.7.2 Integra Lifesciences Business Overview
7.7.3 Integra Lifesciences Regenerative Drugs Major Product Offerings
7.7.4 Integra Lifesciences Regenerative Drugs Revenue in Global Market (2017-2022)
7.7.5 Integra Lifesciences Key News
7.8 Acelity
7.8.1 Acelity Corporate Summary
7.8.2 Acelity Business Overview
7.8.3 Acelity Regenerative Drugs Major Product Offerings
7.8.4 Acelity Regenerative Drugs Revenue in Global Market (2017-2022)
7.8.5 Acelity Key News
7.9 Isto Biologics
7.9.1 Isto Biologics Corporate Summary
7.9.2 Isto Biologics Business Overview
7.9.3 Isto Biologics Regenerative Drugs Major Product Offerings
7.9.4 Isto Biologics Regenerative Drugs Revenue in Global Market (2017-2022)
7.9.5 Isto Biologics Key News
7.10 CryoLife
7.10.1 CryoLife Corporate Summary
7.10.2 CryoLife Business Overview
7.10.3 CryoLife Regenerative Drugs Major Product Offerings
7.10.4 CryoLife Regenerative Drugs Revenue in Global Market (2017-2022)
7.10.5 CryoLife Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Regenerative Drugs Market Opportunities & Trends in Global Market
Table 2. Regenerative Drugs Market Drivers in Global Market
Table 3. Regenerative Drugs Market Restraints in Global Market
Table 4. Key Players of Regenerative Drugs in Global Market
Table 5. Top Regenerative Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Regenerative Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Regenerative Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Regenerative Drugs Product Type
Table 9. List of Global Tier 1 Regenerative Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Regenerative Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Regenerative Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Regenerative Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Regenerative Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Regenerative Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Regenerative Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Regenerative Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Regenerative Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Regenerative Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Regenerative Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Regenerative Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Regenerative Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Regenerative Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Regenerative Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Regenerative Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Regenerative Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Regenerative Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Regenerative Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Regenerative Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Regenerative Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Stryker Corporate Summary
Table 31. Stryker Regenerative Drugs Product Offerings
Table 32. Stryker Regenerative Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Zimmer Biomet Holdings Corporate Summary
Table 34. Zimmer Biomet Holdings Regenerative Drugs Product Offerings
Table 35. Zimmer Biomet Holdings Regenerative Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Medtronic Corporate Summary
Table 37. Medtronic Regenerative Drugs Product Offerings
Table 38. Medtronic Regenerative Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Athersys Corporate Summary
Table 40. Athersys Regenerative Drugs Product Offerings
Table 41. Athersys Regenerative Drugs Revenue (US$, Mn), (2017-2022)
Table 42. STEMCELL Technologies Corporate Summary
Table 43. STEMCELL Technologies Regenerative Drugs Product Offerings
Table 44. STEMCELL Technologies Regenerative Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Organogenesis Corporate Summary
Table 46. Organogenesis Regenerative Drugs Product Offerings
Table 47. Organogenesis Regenerative Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Integra Lifesciences Corporate Summary
Table 49. Integra Lifesciences Regenerative Drugs Product Offerings
Table 50. Integra Lifesciences Regenerative Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Acelity Corporate Summary
Table 52. Acelity Regenerative Drugs Product Offerings
Table 53. Acelity Regenerative Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Isto Biologics Corporate Summary
Table 55. Isto Biologics Regenerative Drugs Product Offerings
Table 56. Isto Biologics Regenerative Drugs Revenue (US$, Mn), (2017-2022)
Table 57. CryoLife Corporate Summary
Table 58. CryoLife Regenerative Drugs Product Offerings
Table 59. CryoLife Regenerative Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Regenerative Drugs Segment by Type in 2021
Figure 2. Regenerative Drugs Segment by Application in 2021
Figure 3. Global Regenerative Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Regenerative Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Regenerative Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Regenerative Drugs Revenue in 2021
Figure 8. By Type - Global Regenerative Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Regenerative Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Regenerative Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Regenerative Drugs Revenue Market Share, 2017-2028
Figure 12. US Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Regenerative Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Regenerative Drugs Revenue Market Share, 2017-2028
Figure 24. China Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Regenerative Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Regenerative Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Regenerative Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Stryker Regenerative Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Zimmer Biomet Holdings Regenerative Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Medtronic Regenerative Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Athersys Regenerative Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. STEMCELL Technologies Regenerative Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Organogenesis Regenerative Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Integra Lifesciences Regenerative Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Acelity Regenerative Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Isto Biologics Regenerative Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CryoLife Regenerative Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
